An official website of the United States government
Publication Information
Affiliation
Division of Digestive and Liver Diseases, Department of Internal Medicine, University of Texas Southwestern Medical Center, Dallas, Texas 75390-8887, USA. William.Lee@utsouthwestern.edu
Authors
Acute Liver Failure Study Group, Blei A, Brown R, Chung R, Crippin J, Davern T, Davern TJ 2nd, Fontana R, Fontana RJ, Han SH, Harrison E, Hassanein T, Hay JE, Hynan L, Hynan LS, Lalani E, Larson AM, Lee WM, McCashland T, McGuire B, Munoz S, Murray N, Murray NG, Murry M, Ostapowicz GA, Pezzia C, Polson J, Reddy R, Reisch J, Reisch JS, Reuben A, Robuck PR, Rossaro L, Samuel G, Sanders C, Satyanarayana R, Schilsky M, Schiødt FV, Shaikh AO, Smith A, Smith JP, Stravitz RT, Webster JW, Zaman A
Studies
Citation
Lee WM, Hynan LS, Rossaro L, Fontana RJ, Stravitz RT, Larson AM, Davern TJ 2nd, Murray NG, McCashland T, Reisch JS, Robuck PR, Acute Liver Failure Study Group. Intravenous N-acetylcysteine improves transplant-free survival in early stage non-acetaminophen acute liver failure. Gastroenterology 2009 Sep;137(3):856-64, 864.e1. Epub 2009 Jun 12.Abstract
N-acetylcysteine (NAC), an antidote for acetaminophen poisoning, might benefit patients with non-acetaminophen-related acute liver failure.